Debt-to-equity of ZEVRA THERAPEUTICS, INC. from 30 Sep 2015 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ZEVRA THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2015 to 31 Dec 2025.
  • ZEVRA THERAPEUTICS, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was 121%, a 52% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ZEVRA THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 121% -128% -52% 31 Dec 2025
Q3 2025 165% -45% -21% 30 Sep 2025
Q2 2025 198% +4.7% +2.4% 30 Jun 2025
Q1 2025 275% +136% +98% 31 Mar 2025
Q4 2024 249% +144% +136% 31 Dec 2024
Q3 2024 210% +138% +191% 30 Sep 2024
Q2 2024 194% +146% +302% 30 Jun 2024
Q1 2024 139% +101% +261% 31 Mar 2024
Q4 2023 105% +81% +331% 31 Dec 2023
Q3 2023 72% +58% +394% 30 Sep 2023
Q2 2023 48% +39% +440% 30 Jun 2023
Q1 2023 39% +34% +693% 31 Mar 2023
Q4 2022 24% +19% +328% 31 Dec 2022
Q3 2022 15% -20% -58% 30 Sep 2022
Q2 2022 8.9% -183% -95% 30 Jun 2022
Q1 2022 4.9% +221% 31 Mar 2022
Q4 2021 5.7% +122% 31 Dec 2021
Q3 2021 35% +151% 30 Sep 2021
Q2 2021 192% +308% 30 Jun 2021
Q1 2021 -217% -101% -88% 31 Mar 2021
Q4 2020 -117% +1.9% +1.6% 31 Dec 2020
Q3 2020 -116% +8.7% +7% 30 Sep 2020
Q2 2020 -116% +8.5% +6.8% 30 Jun 2020
Q1 2020 -115% +16% +12% 31 Mar 2020
Q4 2019 -119% +19% +14% 31 Dec 2019
Q3 2019 -125% +22% +15% 30 Sep 2019
Q2 2019 -125% +45% +27% 30 Jun 2019
Q1 2019 -131% +68% +34% 31 Mar 2019
Q4 2018 -138% +106% +43% 31 Dec 2018
Q3 2018 -147% +160% +52% 30 Sep 2018
Q2 2018 -170% +249% +59% 30 Jun 2018
Q1 2018 -200% +480% +71% 31 Mar 2018
Q4 2017 -243% +855% +78% 31 Dec 2017
Q3 2017 -306% +971% +76% 30 Sep 2017
Q2 2017 -419% +912% +69% 30 Jun 2017
Q1 2017 -679% +654% +49% 31 Mar 2017
Q4 2016 -1099% -746% -212% 31 Dec 2016
Q3 2016 -1277% -1079% -544% 30 Sep 2016
Q2 2016 -1331% 30 Jun 2016
Q1 2016 -1333% 31 Mar 2016
Q4 2015 -352% 31 Dec 2015
Q3 2015 -198% 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.